Ukule retweeted
I knew I was getting myself into trouble, but the truth is, I wasn't exactly doing my best to avoid it.
She moved closer, placed my hand between her thighs and asked me quietly:
"So, what are you going to do?"
I stared at her for a moment. I tried to resist, but I won't lie and pretend I was putting up a serious fight.
Eventually, I gave in.
I pulled her closer, eased her back onto the couch and wrapped my arms around her.
She let out a soft gasp and looked at me.
"What are you going to do with me now?" she whispered.
I brushed my fingers through her hair, looked into her eyes and kissed her.
One kiss turned into another, and suddenly, I had completely forgotten why I invited her over in the first place.
I called her over for company.
I wasn't prepared for the kind of company she came to offer.
Ukule retweeted
Olhei os comentários desse vídeo e está todo mundo julgando as meninas, mas, se você reparar bem, vai perceber ele está atrapalhando elas
Ukule retweeted
i mean, yeah, i had a friend who hit me up to hang for the first time in quite a while, and i couldn’t because i had work in the morning, told him we’d get up another time. a few days later i found out he’d taken his own life.
Ukule retweeted
New Phase 3 HSV trial results have been posted to the EU registry
On November 11, AiCuris posted the technical and plain-language results from the Phase 3 PRIOH-1 trial to the EU clinical-trial registry.
The study evaluated pritelivir in immunocompromised patients with difficult-to-treat mucocutaneous HSV infections that had not responded to standard antivirals. Complete lesion healing by day 28 was reported in 63% of patients receiving pritelivir, compared with 34% receiving the investigator-selected treatment.
This is encouraging because pritelivir works differently from older antivirals and offers an oral option for patients with very limited alternatives. These results already supported its recent U.S. approval, and their publication in the EU registry makes the detailed trial information more accessible.
It is not yet a broadly approved treatment for everyone living with HSV, but it represents meaningful progress and further validates helicase–primase inhibitors as an important new class of HSV treatments.
EU trial record:
euclinicaltrials.eu/ctis-pub…
ClinicalTrials.gov:
clinicaltrials.gov/study/NCT…
Ukule retweeted
"Why didn't you tell me?"
She wiped her tears.
"Because your biological parents disappeared, and we were afraid of losing you."
Daniel looked at the house key.
An address was attached to it.
That afternoon, he visited the house.
An elderly woman opened the door.
The moment she saw him, she burst into tears.
"Daniel, my son. I knew you would come back."
He stood speechless.
Then she held his face and whispered:
"There's something your father never told you. He wasn't supposed to adopt you. He was supposed to protect you from the people who were looking for you."
Daniel stepped backwards.
"Who was looking for me?"
The woman looked behind him and quietly closed the door.
